Xu et al. found that the expression of CIP2A was higher in cancerous glioma tissues than that in normal tissues; in particular, higher levels of expression were found in high-grade gliomas (grade III–IV) than in low-grade gliomas (grade I–II). This evidence concerns the gene CIP2A and central nervous system cancer.